Wegovy (semaglutide injection) offers a promising solution for individuals with a BMI of 30 or higher or those with a BMI of 27 or higher coupled with weight-related health issues
Stacking retatrutide with other compounds Researchers who use retatrutide alongside other peptides or supplements need to consider timing interactions
Providers making guarantees about specific weight loss amounts or claiming MIC injections 'melt fat' are operating outside evidence-based medicine and should be avoided
Important: Even though Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Victoza, and Trulicity appear on its site, the MEDvidi support team confirmed that they are not prescribing injectable GLP-1s or compounded versions at this time (Nov 17, 2025)
Peptides that demand sterile reconstitution and multi-draw protocols
The future of the compounded GLP-1 market is highly uncertain and we expect our project findings to inform policies promoting safe and equitable access to weight loss treatments." We are pleased to support the work of this extraordinary group of researchers who are sure to inform and advance NIHCMs core missionhelping organizations, policymakers, and other stakeholders improve the affordability and quality of US healthcare, while improving health outcomes, said Avik Roy, CEO of NIHCM.